In digital therapeutics market Government initiatives to support development & adoption of digital therapeutics solutions also provide an impetus for growth of this market. For instance, U.S. Congress authorized Centers for Disease Control and Prevention (CDC) to create Diabetes Prevention Recognition Program (DPRP) & recognize programs that meet evidence-based standards provided by DPRP.
Growth of digital therapeutics market include increasing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, & benefits of digital therapeutics. Factors like lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain growth of this market.
Complete details on this report “Digital Therapeutics Market” spread across 186 Pages, Profiling 11 Companies and Supported with 148 Tables and 36 Figures is now available at www.reportsnreports.com/reports/61…cast-to-2021.html .
The report "Digital Therapeutics Market", The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.
For instance, in 2010, the U.S. Congress authorized the Centers for Disease Control and Prevention (CDC) to create the Diabetes Prevention Recognition Program (DPRP) and recognize programs that meet evidence-based standards provided by DPRP.
Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments)
- Proteus Digital Health, Inc.
- Omada Health, Inc.
- Welldoc, Inc.
- Livongo Health
- Noom Inc.
- Ginger.Io, Inc.
- Propeller Health
- 2morrow Inc.
- Canary Health Inc.
- Mango Health Inc.
Digital therapeutics market is segmented into preventive and treatment/care-based applications. On basis of sales channel, digital therapeutics market is segmented into B2C and B2B sales channel.
B2B segment is estimated to command largest share in 2016 and register highest CAGR in digital therapeutics market, by sales channel.
The global digital therapeutics market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America will continue to lead the global market in the forecast period.
Over the next five years, the growth of the market is likely to be centered on the U.S.
1 Market Overview
2 Market, By Application
3 Market for Preventive Applications
4 Market for Treatment/Care Applications
5 Market, By Sales Channel
6 Market for B2C Sales Channel, By Buyer
7 Market for B2B Sales Channel, By Buyer
8 Market: Geographic Snapshot
North America dominates digital therapeutics market, with U.S. accounting for major share and highest CAGR.
This can be attributed to the growing incidence of chronic diseases, government initiatives to support technological advancements in digital therapeutics, gradually improving reimbursement structure for digital therapeutics solutions, and a growing influx of new startup companies in the market as a result of increasing investments in the digital therapeutics field.
Digital therapeutics refers to health or social care interventions delivered through a smart device to support healthy behaviors & provide therapeutic effects. Digital therapies/programs are cost-effective & have potential to improve patient engagement and bring a substantial change in patients’ health.
Owing to these advantages, digital therapeutics is increasingly being prescribed to help manage long-term conditions like diabetes, insomnia, & asthma.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios of top players in digital therapeutics market. Report analyzes digital therapeutics market by application, sales channel, and region
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in digital therapeutics market
- Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the digital therapeutics market
- Market Development: Comprehensive information about lucrative emerging markets. Report analyzes market for various digital therapeutics products across geographies
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in digital therapeutics market.